• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » April 2013 – The CenterWatch Monthly : PDF
April 2013 – The CenterWatch Monthly : PDF

April 2013 – The CenterWatch Monthly : PDF

$79.00

Product Details

20 Innovators Changing the Face of the Clinical Trials Industry

Marking CenterWatch’s 20th anniversary of its flagship publication The CenterWatch Monthly, we are publishing a special commemorative issue focusing on 20 innovators disrupting and transforming the drug development paradigm.

Although the industry is notoriously resistant to change, forward-thinking leaders realize they must explore new approaches in order to transform drug development and revitalize the industry. Many of the new approaches involve collaboration, which can be more efficient, quicker and can achieve better outcomes than R&D centered in pharmaceutical companies.

“From collaboration to crowdsourcing to consolidation, these innovations and the people behind them truly are making a difference,” said Joan Chambers, chief operating officer of CenterWatch. “At every phase of development—from early R&D to study conduct to post-approval—innovators share a common vision: to engage patients and other stakeholders as partners in the process to deliver new treatments to patients more quickly, safely and efficiently...”

Also in this issue:

  • Implications of FDA draft guidance: Assessing investigator qualifications
  • Is your study in need of a rescue?
  • Regulatory Update
  • Month in Review
  • FDA Actions
  • Study Lead Opportunities
  • New Drugs in the Pipeline
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing